1. Class action lawsuit initiated against Charming Medical Limited (MCTA). 2. SEC alleges false and misleading statements affected share prices. 3. Class period lasts from October 21 to November 12, 2025. 4. Shareholders encouraged to participate in legal proceedings for recovery. 5. Deadline for class participation is February 17, 2026.
FAQ
Why Bearish?
Legal issues often lead to decreased investor confidence and share price. Historical cases show similar declines after announcement of lawsuits, indicating potential long-term impacts.
How important is it?
Ongoing litigation directly impacts MCTA's reputation and market position. Investor confidence typically wanes during legal battles, affecting share value.
Why Short Term?
Immediate legal implications can lead to rapid stock volatility. Historical examples illustrate that lawsuits can quickly alter investor sentiment and stock performance.
Related Companies
LOS ANGELES, Dec. 29, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Charming Medical Limited ("Charming " or "the Company") (NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of MCTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD: October 21, 2025 to November 12, 2025
DEADLINE: February 17, 2026
CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. The SEC suspended the trading of Charming shares based on the investigation of an alleged scheme to boost the Company's share price by supposed financial advisors touting shares on social media. Based on these facts, Charming's public statements were false and materially misleading throughout the class period.
If you are a shareholder who suffered a loss, contact us to participate .
WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.
Join the case to recover your losses.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: David@djslawllp.com
View original content:https://www.prnewswire.com/news-releases/charming-medical-limited-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--mcta-302649953.html
SOURCE DJS Law Group LLP